Ispire Technology Inc. Reports Strong Financial Performance for 2024

Sep.27.2024
Ispire Technology Inc. Reports Strong Financial Performance for 2024
Ispire Technology Inc. (NASDAQ: ISPR) reported a record 31.4% revenue increase in their 2024 fiscal year performance.

According to PR Newswire on September 26th, Ispire (Ispire Technology Inc., NASDAQ trading code: ISPR) released its financial performance for the 2024 fiscal year ending on June 30th, 2024, and is submitting its annual report "Form 10-K" to the U.S. Securities and Exchange Commission (SEC) on September 26th.

 

Financial Performance in the 2024 Fiscal Year Shows:

 

  • Income increased by 31.4% year on year to $151.9 million, mainly driven by an increase in sales of American products, which rose from $41.6 million on June 30, 2023 to $63.1 million on June 30, 2024, an increase of $21.5 million; sales of European e-cigarette products increased by $6.5 million, from $58.8 million on June 30, 2023 to $65.3 million on June 30, 2024; sales of e-cigarette products in other markets increased by $5.7 million, from $3.0 million on June 30, 2023 to $6.0 million on June 30, 2024, primarily due to an increase in sales in South Africa to $5.4 million.
  • Gross profit increased by 43.3% from $20.8 million in the 2023 fiscal year to $29.8 million, with a gross margin increasing from 18.0% in 2023 to 19.6%. The increase was mainly due to changes in product mix, focusing on higher-margin products, improved economies of scale due to increased sales volume, and benefits from the company's manufacturing facility in Malaysia.
  • Total operating expenses increased by 73.0% from $25.3 million in the 2023 fiscal year to $43.7 million. This increase was mainly attributed to expenses related to supporting wages and contract labor, sales and marketing, professional fees, and increased stock-based compensation to expand the scope of operations.
  • The net loss was $14.8 million, compared to a net loss of $6.0 million in the 2023 fiscal year.
  • As of June 30, 2024, Ispire had $35.1 million in cash and cash equivalents, and $16.6 million in operating funds.

 

The company's CEO, Michael Wang, stated that...

 

In 2024, it was a foundational year for Ispire characterized by record-breaking revenue and significant profit margin expansion. It also laid the groundwork strategically for faster growth of our global nicotine business, with plans to focus our high-quality marijuana e-cigarette hardware on multi-state operator (MSO) clients.

 

We have established long-term strategic partnerships with industry leaders such as Acreage Holdings, Hidden Hills Club, Dank Pack, and the BRKFST brand collaborated with international singer Burna Boy, expanding market share and strengthening global operational infrastructure.

 

In addition, Ispire has established a 31,000 square feet modern production facility in Malaysia to tap into the international nicotine market, while also reducing costs and increasing profitability.

 

This spring, we successfully completed a $12.3 million initial public offering, strengthened our financial position, and laid the foundation for future international expansion.

 

We have also appointed a senior leadership team, with Jim McCormick as Chief Financial Officer, John Patterson as Senior Vice President of International Nicotine, and Dennis Lider as Senior Vice President of Marijuana E-cigarette Hardware Sales.

 

Ispire recently submitted its first PMTA application in four years for a disposable e-cigarette (ENDS) product with four flavors, marking our attempt to re-enter the U.S. e-cigarette market. The company is focused on driving innovation for growth, improving profit margins, and taking measures to restrict underage use of e-cigarette products, all while adhering to responsible marketing principles.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Product | KT&G Launches lil HYBRID 3.0 Misty Rosé Edition II in South Korea With Two Pink Finishes at 88,000 Won
Product | KT&G Launches lil HYBRID 3.0 Misty Rosé Edition II in South Korea With Two Pink Finishes at 88,000 Won
South Korean tobacco company KT&G launched the limited-edition lil HYBRID 3.0 Misty Rosé Edition II on September 30, 2026, following the original Misty Rosé Edition introduced in November 2025. The new release comes in two pink finishes, Bloom Rosé and Viva Rosé, each priced at 88,000 won. Both versions initially went on sale through the lil Store online shop and lil MINIMALIUM flagship stores. From October 7, Bloom Rosé became available at approximately 1,500 lil Station retail outlets nationwide. The release retains the existing lil HYBRID 3.0 hybrid heated tobacco platform, with changes focused on exterior design and distribution.
product
Oct.10
FRE and ALP Push Modern Oral to 48% of Q2 Sales as Turning Point Brands Changes CEO and Lowers Profit-Guidance Ceiling
FRE and ALP Push Modern Oral to 48% of Q2 Sales as Turning Point Brands Changes CEO and Lowers Profit-Guidance Ceiling
Turning Point Brands said Executive Chairman David E. Glazek will become CEO on October 1, replacing Graham Purdy, who is stepping down for personal reasons. The company narrowed its 2026 adjusted EBITDA outlook to $70 million-$80 million from $70 million-$90 million while maintaining Modern Oral gross sales guidance of $330 million-$350 million and net sales guidance of $260 million-$270 million. In the second quarter, Modern Oral net sales rose 128% to $68.4 million and accounted for 48% of company-wide net sales. Adjusted EBITDA fell 50% year over year. TPB shares closed about 10% lower on September 21.
Market
Sep.22 by 2Firsts Perspectives
Australia Tobacco Tax Debate Spreads Within Labor as NSW Premier Minns Reaffirms Support for a Cut
Australia Tobacco Tax Debate Spreads Within Labor as NSW Premier Minns Reaffirms Support for a Cut
Australia’s tobacco excise debate is increasingly exposing differences within the governing Labor Party. New South Wales Labor Premier Chris Minns reaffirmed on September 8 that he supports reducing tobacco excise, arguing that current tax settings are pushing consumers toward cheaper black-market cigarettes. Federal Health Minister Mark Butler continues to oppose an excise cut, while Treasurer Jim Chalmers and Assistant Treasurer Daniel Mulino have recently stopped short of ruling out future changes. The divergence follows the opposition Coalition’s proposal to cut tobacco excise by 80%.
Sep.08
NAS 2026 | FDA CTP Director Says PMTA Pathway Is “Predicated on Tobacco Harm Reduction”
NAS 2026 | FDA CTP Director Says PMTA Pathway Is “Predicated on Tobacco Harm Reduction”
At the 2026 New Approaches Summit in New York, FDA Center for Tobacco Products Director Bret Koplow said the PMTA pathway is “predicated on tobacco harm reduction.” He outlined four CTP priorities: youth prevention, helping adults quit or switch to lower-risk products, improving relative-risk communication, and reducing unauthorized products. Koplow also addressed flavored e-cigarettes, public risk perceptions, industry credibility and efforts to make PMTA reviews more efficient and predictable.
Sep.26
Special Report|CrossBar's High-Puff Vapes Draw Attention on Pennsylvania's 163-Product Directory as Link Between Earlier 1.3mL PMTA Filings and New 13mL Products Remains Unclear
Special Report|CrossBar's High-Puff Vapes Draw Attention on Pennsylvania's 163-Product Directory as Link Between Earlier 1.3mL PMTA Filings and New 13mL Products Remains Unclear
Pennsylvania began enforcing its electronic nicotine delivery system directory restrictions on October 19, 2026. Among 163 product listings recorded before enforcement, four CrossBar 20K disposables stood out with 13mL capacity, advertised puff counts of up to 20,000 and a flattened design distinct from conventional pod systems and compact disposables. Historical records identify earlier 1.3mL CrossBar products associated with Romo LLC, while newer 13mL products appeared in several state directories beginning in 2025 under entities including Blue Nine LLC. PMTA compliance expert Mr. K identified amendments and application ownership transfers as possible regulatory mechanisms, although neither has been confirmed in this case. Separately, Reynolds' $7.5 million acquisition of 16 PACHA products and related assets illustrates the commercial value of products linked to historic PMTA submissions.
Special Report
Oct.22
JUUL2 Sued Within a Week of FDA Authorization as AJ Marketing Alleges Infringement of Programmable Vape Patent
JUUL2 Sued Within a Week of FDA Authorization as AJ Marketing Alleges Infringement of Programmable Vape Patent
Less than a week after JUUL2 received U.S. FDA marketing authorization on August 28, 2026, JUUL Labs was sued for patent infringement in federal court in Delaware. AJ Marketing LLC filed the complaint on September 3, alleging that both JUUL 1 and JUUL2 infringe U.S. Patent No. 8,851,068 B2. The patent covers aspects of programmable electronic vaporization devices, including controls over dose delivery, usage frequency and operating parameters. The plaintiff is seeking reasonable royalties and ongoing royalties tied to the remaining life of the patent. JUUL has not yet publicly responded to the case.
Sep.10